Enliven Therapeutics, Inc. ($ELVN)
Hohl Benjamin โ CHIEF FINANCIAL OFFICER
Shares
13,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Hohl Benjamin |
|---|---|
| Title | CHIEF FINANCIAL OFFICER |
| Transaction Date | Dec 22, 2025 |
| Expiration Date | Aug 2, 2031 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Dec 23, 2025 |
| Document Date | Dec 22, 2025 |
| Shares Purchased | 13,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 92,056 |
| Derivative | Derivative |
| Accession Number | 0001882764-25-000005 |
| Document | View SEC Filing |